Proton therapy is a promising, but costly, treatment for prostate cancer.
Theoretical physical advantages exist; yet to date, it has been shown only to be comparably safe and effective when compared with the alternatives and not necessarily superior. If clinically meaningful benefits do exist for patients, more rigorous study will be needed to detect them and society will require this to justify the investment of time and money. New technical advances in proton beam delivery coupled with shortened overall treatment times and declining device costs have the potential to make this a more cost-effective therapy in the years ahead.
Written by:
Efstathiou JA, Gray PJ, Zietman AL. Are you the author?
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Reference: Br J Cancer. 2013 Apr 2;108(6):1225-30.
doi: 10.1038/bjc.2013.100
PubMed Abstract
PMID: 23481182
UroToday.com Prostate Cancer Section
